Business Context and Reporting Period
Company: Alcon, Inc.
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: Quarter ended March 31, 2002
Context: Alcon, formerly a wholly-owned subsidiary of Nestle S.A., completed its Initial Public Offering (IPO) on March 20, 2002. The filing details the financial impact of the IPO, the conversion of Nestle's common shares into redeemable preferred shares, and the adoption of new U.S. GAAP accounting standards (FAS 142 and 144).
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2002 | Q1 2001 |
|---|---|---|
| Sales | $706.5 | $654.8 |
| Gross Profit | $496.1 | $470.3 |
| Gross Margin | 70.2% | 71.8% |
| Operating Income | $151.6 | $152.1 |
| Net Earnings | $94.0 | $84.4 |
| Diluted EPS | $0.33 | $0.28 |
| Cash from Operations | $8.4 | $83.0 |
| Cash & Equivalents (End of Period) | $1,819.3 | $989.4 |
| Short-term Borrowings | $947.7 | $805.5 |
| Long-term Debt | $88.4 | $697.4 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 7.9% year-over-year, driven by a 15.9% increase in pharmaceutical sales (notably TRAVATAN and Patanol). Constant currency sales growth was 10.9%, offset by a 3.0% negative currency impact due to a strong U.S. dollar.
- Profitability: Net earnings rose 11.4% to $94.0 million. However, operating income remained flat (-0.3%) due to one-time charges of $22.6 million related to deferred compensation plan changes. Excluding these charges and accounting changes, operating income increased 7.1%.
- Capital Structure: The company raised $2,188.1 million in net IPO proceeds. This was used to pay a $1,243.4 million dividend/return of capital to Nestle and repay $612.7 million in long-term debt. Consequently, long-term debt dropped significantly, while short-term borrowings increased to $947.7 million to fund operations and the upcoming preferred share redemption.
- Accounting Changes: Adoption of FAS 142 eliminated goodwill amortization, providing a $10.6 million benefit to operating income compared to the prior year's treatment.
Outlook, Risks, and Unusual Items
- Preferred Share Redemption: Alcon expects to redeem Nestle's preferred shares (valued at CHF 3.634 billion) prior to May 31, 2002. The company anticipates an increase in short-term borrowings of approximately $500 million to facilitate this transaction.
- Liquidity: Management expects to meet liquidity needs through existing cash ($1.9 billion), short-term investments, and credit facilities totaling $3.3 billion.
- Unusual Items: A one-time charge of $22.6 million ($14.2 million net of tax) was recorded in Q1 2002 related to changes in the deferred compensation plan in connection with the IPO.
- Risks: Key risks include foreign exchange rate fluctuations (hedged via forward contracts), interest rate volatility on floating-rate debt, and potential product recalls or regulatory changes. The company also faces credit risk in high-inflation countries (e.g., Turkey, Brazil, Argentina).
Investor Verification Checklist
- Preferred Share Redemption: Verify the timing and funding source for the redemption of Nestle's preferred shares expected before May 31, 2002.
- Debt Composition: Confirm the sustainability of the increased short-term debt ($947.7 million) and the reliance on commercial paper facilities.
- One-Time Charges: Assess the impact of the $22.6 million deferred compensation charge on future operating margins.
- Currency Exposure: Review the effectiveness of hedging strategies given the reported 3.0% negative currency impact on sales.
- Product Growth: Validate the continued growth trajectory of key pharmaceutical products (TRAVATAN, Patanol) which drove the majority of revenue increases.